Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology/Infectious Diseases | Pediatrics/Neonatology
Disease Category: Vaccines
Trial Information
Hematopoietic Cell Transplantation
Vical Incorporated is currently conducting a phase 2 study to
evaluate the safety, immunogenicity, and clinical benefit of a
study vaccine in controlling CMV recurrent infection in recipients
undergoing hematopoietic cell transplantation, and their respective
donors.
Study drug and study procedures will be made available to you at
no cost.
To qualify, you must:
- Be 18 – 65 years of age
- Be an allele-matched related donor to be considered as a donor
for this study
- Be CMV-seropositive and able to and willing to be followed for
1 year to be a recipient
You will not qualify as a donor if you:
- Are pregnant or breast-feeding
- Have evidence of immunodeficiency
- Have a history of recent immunization, prior CMV therapy, or
administration of an experimental CMV vaccine
You will not qualify as a recipient if you:
- Have an autoimmune disease
- Are a poor risk patient
- Have a certain type of anemia
For more information,
Ira Braunschweig, MD
Biomedical Research Alliance of New York
Montefiore Medical Center
111 East 210th Street
Bronx, NY 10467
Phone: 718-920-4826
View Google Map
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
